KLRG-1+ CD8 T cells displayed a lower frequency in tumors compared with peripheral blood from patients with breast, cervical, esophageal, gastric, and colorectal cancers but not with kidney, lung, and liver cancers (Supplementary Figure 2C). This evidence concerns the gene KLRG1 and colorectal cancer.